Resistant Starch
Starch that escapes digestion in the small intestine and is fermented in the colon, where it is unusually good at producing butyrate specifically.
Resistant Starch quick facts
| Suggested dose | 10–30 g daily of raw potato starch (~1–4 tbsp). Build slowly. |
| How often | Daily, built slowly |
| Who it's for | Anyone targeting butyrate production or post-meal glucose. |
The most direct dietary route to butyrate, and cheaper than supplementing butyrate itself. It causes substantial gas initially in most people, which usually settles over a couple of weeks as the microbiome adapts — that adaptation is the point. Raw potato starch is the cheapest source and must not be cooked. Poorly tolerated in overgrowth.
How Resistant Starch actually works
Starch that escapes small-intestinal digestion and reaches the colon intact, where it is the most potent butyrate-producing substrate available. Type 2 from raw potato or green banana is granular and resists digestion structurally; cooking then cooling starch creates type 3 by retrogradation, which is why cold rice and potato behave differently from hot.
Where to get Resistant Starch
Find Resistant Starch on iHerb →The evidence for Resistant Starch
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show increased fecal butyrate — more reliably than most other fibers.
- Meta-analyses show improved insulin sensitivity, though the effect is clearer in men than in women and the reason for that split is not understood.
- Reduces post-meal glucose when the starch replaces digestible starch in the same meal.
📊 Correlative data
- Populations with higher resistant-starch intake show lower colorectal cancer rates. The CAPP2 trial found a delayed reduction in non-colorectal cancers in Lynch syndrome, which is intriguing but a specific population.
🧪 Theoretical / extrapolated benefits
- Butyrate is the primary fuel for colonocytes; supplying it locally by fermentation is mechanistically different from swallowing a butyrate capsule.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Resistant Starch actually does
Resistant starch is a physical state, not a molecule. The chemistry is amylose and amylopectin, the same glucose polymers as any other starch; what makes it resistant is crystal packing. In a raw potato or green banana granule the amylose chains sit in a tightly hydrogen-bonded B-type polymorph that pancreatic alpha-amylase cannot get its active site into. Heat plus water swells and unwinds that crystal — gelatinization — and the moment it unwinds the starch is ordinary food. Cool it again and some of the amylose recrystallizes into a different, smaller-crystal form, which is the third type of resistant starch and is why cold rice and cooled potato are not the same as hot ones.
The fermentation product is the point, and it is butyrate. Starch that reaches the colon is fermented by amylolytic anaerobes and yields a short-chain fatty acid mixture unusually weighted toward butyrate rather than acetate. Butyrate is not a generic “good compound”: it is the preferred oxidative fuel of the colonocyte, and the demonstration is a clean one. Germ-free mice, which have no fermentation and therefore no butyrate, show colonocytes in an energy deficit with reduced NADH/NAD+, decreased ATP and an autophagic response — and butyrate alone rescues it Donohoe 2011. The colon is the one tissue in the body that eats what your bacteria make rather than what your blood delivers.
Two consequences that follow from that and are rarely connected. First, colonocytes burning butyrate consume oxygen at the mucosal surface, which keeps the lumen anaerobic and holds down the facultative anaerobes — Enterobacteriaceae — that expand when it is not. Second, butyrate is a histone deacetylase inhibitor, but only when it is not being burned. A healthy colonocyte oxidizes it and little reaches the nucleus; a glycolytic cell does not, so butyrate accumulates and acts as an HDAC inhibitor there. Same molecule, two entirely different jobs depending on the metabolic state of the cell it enters.
Why swallowing butyrate is not the same experiment. Free butyrate taken by mouth is absorbed in the upper gut and smells of rancid butter on the way. Fermenting starch generates it in the colonic lumen, adjacent to the cells that use it, at a rate set by how fast the substrate arrives. The delivery route is the drug.
Cell, rodent, human — and where it stops
In rodents. The colonocyte energy story was built in germ-free and conventionalized mice, with butyrate given directly to isolate the molecule from the microbiome Donohoe 2011. That is mechanism, not a claim about a scoop of powder.
In humans, on the metabolic endpoint, with a split nobody expected. Healthy volunteers who ate resistant starch for a short period showed enhanced postprandial insulin sensitivity afterwards Robertson 2003. Then 33 overweight and obese adults — 11 men and 22 women, mean BMI 30.6 — took high-amylose maize type-2 resistant starch at 15 or 30 g/day for four-week periods separated by three-week washouts. Insulin sensitivity improved in the MEN at both doses (P < 0.05) and there was no significant effect in the WOMEN Maki 2012. The card on this page says the effect is clearer in men and that nobody knows why; that trial is where that sentence comes from, and the sex split is the finding, not a footnote.
In humans, on the fermentation endpoint. Eighty adults ate bread and biscuits made from high-amylose or conventional wheat for four weeks. The high-amylose refined arm excreted 38% more fecal butyrate than the low-amylose refined arm (P < 0.05), raised Roseburia inulinivorans, and lowered fecal p-cresol — a product of protein rather than carbohydrate fermentation Gondalia 2022. That is the mechanism turning up in a person, at a food dose.
And the trial that did not work, which belongs here. Nineteen adults at risk of type 2 diabetes ate 300 g/day of resistant-starch-enriched potatoes — about 18 g of resistant starch — in an acute crossover. Insulin sensitivity did not differ from control. What did move: breath hydrogen rose (P = 0.037), postprandial free fatty acids fell (P = 0.039) and fasting glucose fell (P = 0.043) Sanders 2021. Breath hydrogen is direct proof the starch reached the colon; the insulin endpoint still did not shift in a day.
The long trial, and its result is not the one people quote. In CAPP2, 463 people with Lynch syndrome took 30 g/day of resistant starch and 455 took placebo, for up to four years, with cancer outcomes followed for twenty. Colorectal cancers: 52 against 53 — no difference. Non-colorectal Lynch syndrome cancers: 27 against 48, hazard ratio 0.54, P = 0.010, with upper gastrointestinal cancers 5 against 21 Mathers 2022. A colonic fermentation substrate did nothing in the colon and appeared to do something above it.
The obstacle, and it is the source of the starch. Every metabolic and fermentation result above used high-amylose maize or high-amylose wheat Maki 2012 Gondalia 2022 Mathers 2022. Almost every person taking this at home uses raw potato starch, on the strength of internet dosing advice, and no trial has tested raw potato starch at 20–30 g/day for a metabolic endpoint. The one potato study is acute and negative on that endpoint Sanders 2021.
Resistant Starch — which form, and does it matter
The four types are four different products. Type 1 is starch physically trapped in intact cell walls — whole grains, legumes. Type 2 is the native crystalline granule: raw potato starch, green banana, high-amylose maize. Type 3 is retrograded starch from cooked and cooled food. Type 4 is chemically modified — cross-linked or esterified — and it is a different substrate that ferments differently and is not what any of the trials above used.
Grams of powder are not grams of resistant starch. Raw potato starch is roughly half to two-thirds resistant starch by weight, so a tablespoon of powder is not a tablespoon of the thing being dosed. When a trial says 30 g Mathers 2022 it means 30 g of resistant starch, and matching that with potato powder takes appreciably more powder than the number suggests. Read the panel for grams of resistant starch, not grams of product.
Heat destroys it, and the temperature is lower than people think. Potato starch gelatinizes in the low 60s Celsius, which is below the temperature of coffee, below a warm smoothie left out, and well below baking. Stirring it into anything hot converts an expensive prebiotic into a cheap carbohydrate, and nothing about the taste or texture tells you it happened.
High-amylose maize is the form with the evidence, and it is heat-stable in a way potato starch is not. That is the practical reason it was the material in the trials Maki 2012 Gondalia 2022: it survives being baked into a food, which makes a controlled feeding study possible. Choosing potato starch is choosing the cheaper substrate with none of the metabolic trial data.
What would have to be true, and how you would know it was not
1. Gas in week one is the assay, and its absence means the dose did not arrive. Breath hydrogen rose measurably when resistant starch was eaten Sanders 2021, and hydrogen is made only by fermentation. So predict noticeable gas within 3–7 days of a real dose, settling over two to four weeks. If there is no gas at all, either the starch was heated or the dose is far under the trial range, and no other endpoint is going to move.
2. Fasting insulin, with the sex caveat stated up front. Predict fasting-insulin falls modestly at four weeks in a man with a raised baseline on 15–30 g/day Maki 2012, and predict no reliable change in a woman on the same dose. That is an uncomfortable prediction and it is the one the best-controlled trial supports. Retest at 4 and 12 weeks.
3. The prediction that cuts against the product. Predict hba1c does NOT move at 12 weeks. The human trials moved a post-meal insulin measure and a fermentation marker, not a three-month glucose average, and the acute potato study did not even move insulin sensitivity Sanders 2021. A fall of 0.3 percentage points or more in hba1c with diet and weight genuinely unchanged would be a new result that no published trial predicts.
4. Fecal butyrate is the direct read-out and it has a known effect size. Predict roughly a third more butyrate excreted at four weeks Gondalia 2022. And note the trap: fecal butyrate is what was left after the colon absorbed what it wanted, so a flat number can mean less production or more uptake. That ambiguity is why nobody should treat a stool SCFA panel as a scoreboard.
5. If you are taking it for the CAPP2 result, be clear what you are predicting. That trial's benefit was outside the colon, in people with a specific DNA mismatch-repair defect, over twenty years Mathers 2022. There is no marker that reads out on that in your lifetime of self-experimentation, and pretending otherwise is the single most common misuse of this citation.
What nobody has tested yet
Nobody knows why it works in men and not women. The trial that found it had 22 women in it — two thirds of the sample — so this is not a power problem in the obvious direction Maki 2012. Sex hormones, body-fat distribution and microbiome composition are all candidates and no study has been designed to separate them. It is the most interesting open question in the fiber literature and it has sat untouched for over a decade.
Nobody has run raw potato starch against high-amylose maize. The whole popular protocol uses one substrate and the whole evidence base uses the other. A four-week crossover with matched grams of resistant starch and an insulin measure would settle it, and it does not exist.
Nobody can explain CAPP2's upper-gastrointestinal result. Five cancers against 21 Mathers 2022 is a large signal from a substrate that is fermented downstream of every organ involved. Either there is a systemic mediator nobody has identified, or it is a play of chance in a secondary endpoint. No mechanistic study has been done either way, and CAPP3 was not designed to answer it.
And nobody has measured butyrate where it matters. All human data is fecal — the leftovers. Colonic luminal butyrate has been measured in sudden-death autopsy series and not in a living person on a supplement, so the concentration the colonocyte actually sees during any of these trials is unknown.
Resistant Starch — its own safety story, not its category's
The gas is not a settling-in period for everyone, and the dose-response is steep. The near-universal week-one flatulence is the fermentation working, and going straight to four tablespoons is why most people quit. Raw potato starch is the harshest of the type-2 sources. Quarter dose, build over a month; and if week three is worse than week one, that is not adaptation failing, it is a signal.
Small intestinal bacterial overgrowth changes the calculation specifically. Resistant starch is designed to pass the small intestine intact, which in principle makes it a better choice than a rapidly fermented oligosaccharide. But if fermenting organisms are already established upstream, the fermentation happens in a segment with far less gas-handling capacity than the colon, and the result is pain rather than flatus. Anyone whose bloating is upper-abdominal and starts within an hour of a dose is describing that, and should stop rather than titrate.
It lowers post-meal glucose, which is additive with the drugs that also do. Fasting glucose fell in the acute potato study Sanders 2021 and post-meal glucose falls when resistant starch replaces digestible starch in the same meal. On a sulfonylurea, on insulin, or on a fixed prandial dose, that is a hypoglycemia risk rather than a bonus. Test around meals in the first fortnight.
The under-reported upside, stated as a safety point. Feeding the colon carbohydrate reduces how much protein is fermented there: fecal p-cresol, a protein-fermentation product, fell on the high-amylose arm Gondalia 2022. That matters most for anyone on a very high protein intake, and it is the one part of this product's story that is about what it prevents rather than what it adds.
Who should not just start. Anyone with active inflammatory bowel disease, recent diverticulitis, or a stricture: a fermentable load producing gas behind a narrowing is a mechanical problem, and none of the trials above enrolled those people.
Sources read for this page
- Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metabolism 2011 · PMID 21531334
- Maki KC, Pelkman CL, Finocchiaro ET, et al. Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. Journal of Nutrition 2012 · PMID 22357745
- Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN. Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 2003 · PMID 12712245
- Sanders LM, Dicklin MR, Palacios OM, et al. Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross-over randomised controlled trial. Journal of Human Nutrition and Dietetics 2021 · PMID 33119948
- Mathers JC, Elliott F, Macrae F, et al. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up. Cancer Prevention Research 2022 · PMID 35878732
- Gondalia SV, Wymond B, Benassi-Evans B, et al. Substitution of Refined Conventional Wheat Flour with Wheat High in Resistant Starch Modulates the Intestinal Microbiota and Fecal Metabolites in Healthy Adults: A Randomized, Controlled Trial. Journal of Nutrition 2022 · PMID 35102419
How you would know if it worked
These are the markers that recommend this product on their own pages, plus the ones its mechanism names.
- TMAO (Trimethylamine N-oxide) — Resistant starch and prebiotic fiber shift gut composition favorably Retest: 3–6 months after dietary change.
- Fasting Insulin Retest: Every 3–6 months, or 8–12 weeks after an intervention.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Resistant Starch — safety & side effects
- Gas is substantial in the first weeks and is the most common reason people stop. Raw potato starch is the harshest form.
- May worsen symptoms in SIBO. Separate from medication.
- Lowers post-meal blood glucose — worth noting alongside diabetes medication.
The same on every page it applies to. Read it here; it is not repeated research.
- Gas, bloating and cramping in the first weeks are expected and usually settle. Start at a quarter dose and build over a month — going straight to a full dose is why most people abandon fiber.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Resistant Starch in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Resistant Starch
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | Anemia is the commonest sign of a gut absorbing badly |
| Ferritin | Iron is the first thing malabsorption takes |
| Vitamin B12 | The second thing, and the one with permanent consequences |
| hs-CRP (High-Sensitivity C-Reactive Protein) | Separates inflammatory bowel disease from IBS |
The Gut Health & Absorption panel covers these in one order — 11 markers, $208.80 with the discount applied.
Check results you already have → · All 103 markers A–Z
Resistant Starch — frequently asked questions
What is Resistant Starch?
Starch that escapes digestion in the small intestine and is fermented in the colon, where it is unusually good at producing butyrate specifically.
What is the suggested dose of Resistant Starch?
10–30 g daily of raw potato starch (~1–4 tbsp). Build slowly. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Resistant Starch dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Resistant Starch?
Coach Cam sources Resistant Starch from vetted, top-rated brands on iHerb — use the buy link on this page.
What Resistant Starch is used for
Resistant Starch appears under 1 goal in the goal router.
Related Gut & Digestion supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.